XML 20 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Profit or Loss [Abstract]      
Research and development expenses $ 7,620 $ 17,034 $ 16,320
Sales, general and administrative expenses 3,183 5,237 6,283
Impairment loss 202
Operating Loss 11,005 22,271 22,603
Change in fair value of warrants (3,341) (3,497)
Finance expenses 483 2,195 67
Finance income (868) (992) (910)
Finance income, net (3,726) (2,294) (843)
Loss for the year 7,279 19,977 21,760
Items that will be transferred to profit or loss:      
Loss (profit) from cash flow hedges 19 (25) 6
Total comprehensive loss for the year 7,298 19,952 21,766
Loss attributable to:      
Owners of the Company 7,240 19,880 21,668
Non-controlling interests 39 97 92
Loss for the year 7,279 19,977 21,760
Total comprehensive loss attributable to:      
Owners of the Company 7,259 19,855 21,674
Non-controlling interests 39 97 92
Total comprehensive loss for the year $ 7,298 $ 19,952 $ 21,766
Loss per share data      
Basic loss per ADS - USD (in Dollars per share) $ 4.44 $ 17.96 [1] $ 23.97 [1]
Diluted loss per ADS - USD (in Dollars per share) $ 4.99 $ 17.96 [1] $ 23.97 [1]
Number of ADSs used in calculating basic loss per ADS (in Shares) 1,639,566 1,106,665 [1] 904,054 [1]
Number of ADSs used in calculating diluted loss per ADS (in Shares) 1,639,787 1,106,665 [1] 904,054 [1]
[1] Restated to reflect a 1:20 reverse ratio of the ADS’s, that took place September 2024 (see Note 9A)